EHC

SEC source: 0001127602-23-001359 · form5.xml · nonDerivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President & CEO, HHH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,339

F1 · kind: Represents shares of Common Stock that the reporting person donated as a gift to a donor advised fund administered by the American Endowment Foundation.

F2 · balance_after: Reflects number of shares owned as of June 30, 2022, Ms. Jacobsmeyer's last day of employment with the issuer.

SEC source: 0001127602-22-007738 · form4.xml · derivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,039

Underlying: Encompass Health Common Stock · 61,039 shares

Expires 2032-03-01

F1 · derivative.exercise_date: The option becomes exercisable in equal annual installments over a three-year period commencing March 1, 2023.

SEC source: 0001127602-22-007736 · form4.xml · derivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President & CEO, HHH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,137

Underlying: Encompass Health Common Stock · 22,137 shares

Expires 2032-03-01

F1 · derivative.exercise_date: The option becomes exercisable in equal annual installments over a three-year period commencing March 1, 2023.

SEC source: 0001127602-22-007735 · form4.xml · derivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,715

Underlying: Encompass Health Common Stock · 10,715 shares

Expires 2032-03-01

F1 · derivative.exercise_date: The option becomes exercisable in equal annual installments over a three-year period commencing March 1, 2023.

SEC source: 0001127602-22-007734 · form4.xml · derivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,728

Underlying: Encompass Health Common Stock · 22,728 shares

Expires 2032-03-01

F1 · derivative.exercise_date: The option becomes exercisable in equal annual installments over a three-year period commencing March 1, 2023.

SEC source: 0001127602-22-006969 · form4.xml · nonDerivative · entry 3

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,403

F3 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020.

SEC source: 0001127602-22-006969 · form4.xml · nonDerivative · entry 2

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,139

F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-22-006970 · form4.xml · nonDerivative · entry 3

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,557

F3 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020.

SEC source: 0001127602-22-006970 · form4.xml · nonDerivative · entry 2

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 396,827

F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-22-006966 · form4.xml · nonDerivative · entry 3

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,800

F3 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020.

SEC source: 0001127602-22-006966 · form4.xml · nonDerivative · entry 2

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,228

F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-22-006968 · form4.xml · nonDerivative · entry 3

Jacobsmeyer Barbara Ann · CIK 0001691132 · President & CEO, HHH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,539

F3 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020.

SEC source: 0001127602-22-006968 · form4.xml · nonDerivative · entry 2

Jacobsmeyer Barbara Ann · CIK 0001691132 · President & CEO, HHH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,664

F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-22-006967 · form4.xml · nonDerivative · entry 3

Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,477

F3 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020.

SEC source: 0001127602-22-006967 · form4.xml · nonDerivative · entry 2

Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,348

F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-22-006965 · form4.xml · nonDerivative · entry 3

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,948

F3 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020.

SEC source: 0001127602-22-006965 · form4.xml · nonDerivative · entry 2

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,132

F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-22-006964 · form4.xml · nonDerivative · entry 3

Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,653.061

F3 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020.

SEC source: 0001127602-22-006964 · form4.xml · nonDerivative · entry 2

Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,119.061

F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-22-006969 · form4.xml · nonDerivative · entry 1

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,821

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006970 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380,569

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006966 · form4.xml · nonDerivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,374

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006968 · form4.xml · nonDerivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President & CEO, HHH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,767

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006967 · form4.xml · nonDerivative · entry 1

Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,168

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006965 · form4.xml · nonDerivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,078

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006964 · form4.xml · nonDerivative · entry 1

Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,247.061

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006355 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,442

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006352 · form4.xml · nonDerivative · entry 1

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,086

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006349 · form4.xml · nonDerivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President & CEO, HHH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,351

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006347 · form4.xml · nonDerivative · entry 1

Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,415

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006346 · form4.xml · nonDerivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,704

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006345 · form4.xml · nonDerivative · entry 1

Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,543.061

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-006342 · form4.xml · nonDerivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,776

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-22-004024 · form4.xml · derivative · entry 4

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Encompass Health Common Stock · 26,132 shares

Expires 2022-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-22-004024 · form4.xml · nonDerivative · entry 2

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,046

F1 · shares: These shares were withheld or surrendered to pay the insider's option exercise price and tax withholding obligations incurred in connection with the exercise of the stock options scheduled to expire on February 27, 2022.

SEC source: 0001127602-22-004024 · form4.xml · nonDerivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-22-001942 · form4.xml · nonDerivative · entry 1

Reidy Christopher R · CIK 0001290907 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,612

F1 · shares: This number represents the purchase of shares of common stock of Encompass Health Corporation (the "Company") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the "Plan"). The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2021 to defer fixed percentages of their directors fees for 2022. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director.

SEC source: 0001127602-22-001940 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,276

F1 · shares: This number represents the purchase of shares of common stock of Encompass Health Corporation (the "Company") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the "Plan"). The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2021 to defer fixed percentages of their directors fees for 2022. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director.

F2 · price: This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $62.59 to $62.60, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

SEC source: 0001127602-22-001737 · form4.xml · nonDerivative · entry 2

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,027

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 18, 2022, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-22-001734 · form4.xml · nonDerivative · entry 2

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,956

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 18, 2022, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-22-001726 · form4.xml · nonDerivative · entry 2

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,778

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 18, 2022, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-22-001737 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,960

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001738 · form4.xml · nonDerivative · entry 1

Williams Terrance · CIK 0001798480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,281

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001736 · form4.xml · nonDerivative · entry 1

SCHLICHTING NANCY M · CIK 0001376358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,081

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001735 · form4.xml · nonDerivative · entry 1

Reidy Christopher R · CIK 0001290907 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,213

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001734 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,949

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001733 · form4.xml · nonDerivative · entry 1

Maryland Patricia Anne · CIK 0001798468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,927

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001732 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,520

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001731 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,806

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001730 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,520

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.